Maria Cherska: Are We Overlooking the Spleen in Cardiometabolic Research?
Maria Cherska, The Head of Cardiology Department at The State Institution V.P. Komisarenko Institute of Endocrinology and Metabolism, shared a post on LinkedIn about a recent article by Giovanni Tarantino and Vincenzo Citro, published in Lipids in Health and Desease, adding:
”Are we overlooking the spleen in cardiometabolic research?
When discussing lipid metabolism, we often focus on the liver and adipose tissue.
A review by Giovanni Tarantino and Vincenzo Citro, published online as an article in press in Lipids in Health and Disease, brings the spleen into the conversation.
‘The spleen as a metabolic rheostat: orchestrating systemic lipid flux and interorgan crosstalk’ explores how lipid handling, immune activity and communication between organs may intersect.
Three themes caught my attention:
- Cholesterol trafficking: macrophage pathways involved in lipoprotein processing, cholesterol efflux and HDL remodeling.
- Platelet-derived extracellular vesicles: potential links between platelet biology, inflammatory signaling and lipid homeostasis, illustrated in the accompanying figure.
- Spleen–liver communication: mechanisms that may help connect local immune responses with systemic metabolic changes.
For those working in lipidology, obesity and cardiometabolic medicine, this review offers a valuable perspective on the connections between metabolism and immunity.
The authors also make an essential distinction: much of the evidence comes from experimental models or related cellular systems. The integrated spleen-centered model remains a working hypothesis, with important questions still requiring validation in humans.
Which aspect of spleen–lipid–immune communication deserves the most research attention?”
Title: The spleen as a metabolic rheostat: orchestrating systemic lipid flux and interorgan crosstalk
Authors: Giovanni Tarantino, Vincenzo Citro

Other posts featuring Maria Cherska on Hemostasis Today.
-
Nov 12, 2026, 12:04Yazan Abou-Ismail: Pleasure Discussing Factor 11 Inhibitors with Nashwa Abdulsalam at Heart Rhythm TV
-
Nov 12, 2026, 11:57Javed Anees: Asundexian – A New Era in Secondary Stroke Prevention
-
Nov 12, 2026, 10:30Nancy Di Salvo: Protecting Access to IVIG and SCIG – A Call for Continued EU Recognition
-
Nov 12, 2026, 10:28Ali Hammed: Should DOAC Use Exclude Patients From Thrombolysis After Ischemic Stroke?
-
Nov 12, 2026, 10:21Aseem Kumar Tiwari: The Molecular Dimension of HLA Matching
-
Nov 12, 2026, 10:18Sarah Connolly: Developing Advanced Haematology Services in Cancer Care
-
Nov 12, 2026, 10:13Carlos Esteban Gasko: Restrictive Transfusion in Critical Care
-
Nov 12, 2026, 10:07Samin Mohsenian: Advancing Care in Rare Bleeding Disorders
-
Nov 12, 2026, 10:03Influenza Vaccination in Patients With ITP – ITP Support Association